Evidence map›Paper›PMID 39135256›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Prognostic Impact of the Ratio of Hemoglobin to Red Blood Cell Distribution Width in Patients after Acute Decompensated Heart Failure.

Yusuke Kanzaki, Masatoshi Minamisawa, Hirohiko Motoki, Sho Suzuki, Yukari Okuma, Masafumi Kanai, Keisuke Machida, Kazuhiro Kimura, Yasushi Ueki, Koji Yoshie and 6 more

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yusuke KanzakiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Masatoshi MinamisawaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Hirohiko MotokiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Sho SuzukiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Yukari OkumaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Masafumi KanaiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Keisuke MachidaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Kazuhiro KimuraDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Yasushi UekiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Koji YoshieDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Yasutaka OguchiDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Tamon KatoDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Tatsuya SaigusaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Soichiro EbisawaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Ayako OkadaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.
Koichiro KuwaharaDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The ratio of hemoglobin to red blood cell distribution width (Hb/RDW) is a simple and readily available tool associated with adverse outcomes in chronic heart failure (HF). However, the association between the Hb/RDW ratio and mortality in patients with acute decompensated HF (ADHF) is unclear. The goal of this study was to investigate the relationship between the Hb/RDW ratio and mortality in patients after ADHF. Methods This single-center study included clinical and laboratory data collected at baseline, with patients prospectively followed-up for a median period of 3.1 years. The patients were divided into two groups based on their median Hb/RDW ratio. Patients We evaluated 250 consecutive patients hospitalized for ADHF at Shinshu University Hospital between July 2014 and March 2019. Results In our study cohort [median age, 76 (66-83) years; 62.8% male], all-cause death was observed in 91 patients (incidence rate: 12.7 per 100 patient-years). A Kaplan-Meier analysis revealed that patients in the lower Hb/RDW ratio group (<0.24, n=131) had worse outcomes compared to those in the higher group (≥0.24, n=119) (cumulative incidence 44.1% vs. 19.5%, respectively; log-rank, p<0.001). After adjusting for demographics, HF severity, and laboratory biomarkers, a lower Hb/RDW ratio was significantly associated with a higher risk of mortality (hazard ratio, 1.89; 95% confidence interval, 1.04-3.45; p=0.038). Conclusion A lower Hb/RDW ratio is associated with an increased risk of mortality in patients after ADHF, thus indicating its potential utility in identifying patients at an elevated risk for future cardiovascular events.

Indexed as

Erythrocyte IndicesHeart FailureHemoglobinsAcute DiseaseAgedAged, 80 and overBiomarkersFemaleFollow-Up StudiesHumansKaplan-Meier EstimateMalePrognosisProspective StudiesBiomarkersHemoglobinsheart failureprognosisred blood cell distribution width

Identifiers

PMID39135256
PMCPMC11986319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.